Multiple cerebral arterial stenosis associated with hepatitis B virus infection

Journal of Clinical Neurology (Korea)

Volumn 7, Issue 1, 2011, Pages 40-42

  Kim, Joon Tae ^a   Park, Man Seok ^a   Nam, Tai Seung ^a   Choi, Seong Min ^b   Lee, Seung Han ^a   Kim, Byeong Chae ^a   Kim, Myeong Kyu ^a   Cho, Ki Hyun ^a  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University Hwasun Hospital and Medical School   (South Korea)

Author keywords

Atherosclerosis; Hepatitis B virus; Multiple cerebral arterial stenoses; Reactivated HBV infection

Indexed keywords

EID: 79956342939     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2011.7.1.40     Document Type: Review

References (15)

1. Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999;100:e20-e28.
2. Fattovich G, Brollo L, Giustina G, Noventa F, Pontisso P, Alberti A, et al. Natural history and prognostic factors for chronic hepatitis type B. Gut 1991;32:294-298.
3. Wanless IR, Wong F, Blendis LM, Greig P, Heathcote EJ, Levy G. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology 1995;21:1238-1247.
4. Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993;328:1828-1835.
5. Ishizaka N, Ishizaka Y, Takahashi E, Toda Ei E, Hashimoto H, Ohno M, et al. Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers. Circulation 2002;105:1028-1030.
6. Sung J, Song YM, Choi YH, Ebrahim S, Davey Smith G. Hepatitis B virus seropositivity and the risk of stroke and myocardial infarction. Stroke 2007;38:1436-1441.
7. Swartz RH, Bhuta SS, Farb RI, Agid R, Willinsky RA, Terbrugge KG, et al. Intracranial arterial wall imaging using high-resolution 3-tesla contrast-enhanced MRI. Neurology 2009;72:627-634.
8. Mason A, Wick M, White H, Perrillo R. Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection. Hepatology 1993;18:781-789.
9. Deeren DH, De Backer AI, Malbrain ML, Verbraeken H, Blockmans D. Treatment of hepatitis B virus-related polyarteritis nodosa: two case reports and a review of the literature. Clin Rheumatol 2004;23:172-176.
10. Trepo C, Guillevin L. Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis. J Autoimmun 2001;16:269-274.
11. Baig S, Alamgir M. The extrahepatic manifestations of hepatitis B virus. J Coll Physicians Surg Pak 2008;18:451-457.
12. Muhlestein JB. Chronic infection and coronary artery disease. Med Clin North Am 2000;84:123-148.
13. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Mäkelä PH, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-986.
14. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001;103: 1064-1070.
15. Ludewig B, Freigang S, Jäggi M, Kurrer MO, Pei YC, Vlk L, et al. Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model. Proc Natl Acad Sci U S A 2000;97:12752-12757.